ONCAlert | Upfront Therapy for mRCC
Latest From SITC
Augmenting T Cell Immunity in Cold Tumors
7:31 PM, Sat November 10, 2018
Two Rapid-Fire Abstracts Break Down Biomarkers of Response and Resistance
3:53 PM, Mon November 12, 2018
Phase I Study Considers Potential for Personalized Immunotherapy in Glioblastoma
5:42 PM, Sun November 11, 2018
CD8-Tracer Is Safe, Shows Biodistribution of T Cells in Tumors
3:51 PM, Sat November 10, 2018
Computer Analysis Determines Best Practices for Use of Tumor Mutational Burden in Patient Care
3:01 PM, Sat November 10, 2018
Immunologic Biomarker Findings for mFOLFOX6 and Pembrolizumab in CRC
12:16 AM, Sat November 10, 2018
Immunotherapy Pioneers Allison, Honjo Awarded Nobel Prize
6:45 PM, Mon October 1, 2018
An Overview of an Immuno-Oncology Panel for Standardized Profiling of Immune Status
2:55 PM, Wed November 15, 2017
CAR T-Cell Therapy Hits Prime Time; Challenges Remain
3:47 PM, Mon November 13, 2017
Nivolumab/Ipilimumab Combo May Hold Potential in Neoadjuvant Melanoma
3:29 PM, Sun November 12, 2017
